Eagle Asset Management Inc. lessened its position in shares of Healthequity Inc (NASDAQ:HQY) by 0.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 549,662 shares of the company’s stock after selling 1,483 shares during the quarter. Eagle Asset Management Inc. owned approximately 0.78% of Healthequity worth $31,410,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Schaper Benz & Wise Investment Counsel Inc. WI acquired a new stake in shares of Healthequity during the 3rd quarter worth approximately $699,000. Keeler Thomas Management LLC grew its position in shares of Healthequity by 10.8% during the 3rd quarter. Keeler Thomas Management LLC now owns 20,590 shares of the company’s stock worth $1,185,000 after buying an additional 2,005 shares during the period. Kornitzer Capital Management Inc. KS grew its position in shares of Healthequity by 9.9% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 146,340 shares of the company’s stock worth $8,363,000 after buying an additional 13,165 shares during the period. LS Investment Advisors LLC grew its position in shares of Healthequity by 23.0% during the 3rd quarter. LS Investment Advisors LLC now owns 3,540 shares of the company’s stock worth $202,000 after buying an additional 661 shares during the period. Finally, Renaissance Group LLC acquired a new stake in shares of Healthequity during the 3rd quarter worth approximately $440,000. 84.45% of the stock is owned by institutional investors and hedge funds.
In other Healthequity news, CFO Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $61.61, for a total transaction of $246,440.00. Following the completion of the transaction, the chief financial officer now owns 46,000 shares of the company’s stock, valued at approximately $2,834,060. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 12,000 shares of company stock valued at $717,320 in the last ninety days. Insiders own 3.70% of the company’s stock.
Shares of HQY traded up $0.47 during trading hours on Friday, reaching $61.74. The stock had a trading volume of 542,800 shares, compared to its average volume of 931,414. The company has a current ratio of 22.98, a quick ratio of 22.98 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $4.32 billion, a price-to-earnings ratio of 64.99, a P/E/G ratio of 3.50 and a beta of 1.50. Healthequity Inc has a 12 month low of $50.29 and a 12 month high of $100.97. The firm has a 50-day simple moving average of $56.80 and a 200 day simple moving average of $65.14.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.10. The business had revenue of $86.60 million during the quarter, compared to analyst estimates of $85.33 million. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The company’s quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.36 EPS. On average, equities analysts forecast that Healthequity Inc will post 0.87 EPS for the current year.
HQY has been the subject of several recent analyst reports. Zacks Investment Research raised shares of Healthequity from a “sell” rating to a “buy” rating and set a $62.00 price objective for the company in a research report on Tuesday, November 5th. TheStreet downgraded shares of Healthequity from a “b” rating to a “c+” rating in a research report on Tuesday, September 3rd. Goldman Sachs Group assumed coverage on Healthequity in a report on Monday, October 7th. They issued a “neutral” rating and a $56.00 target price on the stock. Wells Fargo & Co cut their target price on Healthequity from $80.00 to $76.00 and set an “outperformer” rating on the stock in a report on Wednesday, September 4th. Finally, Barrington Research reiterated an “outperform” rating and issued a $75.00 target price (down from $100.00) on shares of Healthequity in a report on Wednesday, September 4th. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Healthequity has a consensus rating of “Buy” and a consensus price target of $77.00.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: What is Compound Interest?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.